
Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.
At first glance, Tuesday’s election does not appear to have altered much the country’s health care politics: Many of the same key players and issues will dominate the congressional debate.
Yet the temptation to claim a “status quo” outcome from the election ignores broader trends in this year’s health and Medicare debates, according to longtime congressional observers.
Read full story:
Source: Kaiser Health News





